Liver tissue concentrations of levofloxacin after single intravenous administration of 500 mg for antibiotic prophylaxis in liver surgery

International Journal of Antimicrobial Agents

Volumn 28, Issue 3, 2006, Pages 221-225

  Weinrich, Malte ^a   Scheingraber, Stefan ^a   Stremovskaia, Tatiana ^a   Schilling, Martin K ^a   Kees, Frieder ^b   Pistorius, Georg A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Levofloxacin; Liver penetration; Liver tissue concentration; Pharmacokinetics

Indexed keywords

LEVOFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILIARY TRACT INFECTION; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FATTY LIVER; FEMALE; HUMAN; INFUSION; LIVER RESECTION; LIVER SURGERY; MALE; MICROORGANISM; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUOROMETRY; HEPATECTOMY; HUMANS; LIVER; MALE; MIDDLE AGED; OFLOXACIN;

EID: 33747333855     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.04.012     Document Type: Article

References (21)

1. Westphal J.F., and Brogard J.M. Biliary tract infections - a guide to drug treatment. Drugs 57 (1999) 81-91
2. Swoboda S., Oberdorfer K., Klee F., Hoppe-Tichy T., Von Baum H., and Geiss H.K. Tissue and serum concentrations of levofloxacin 500 mg administered intravenously or orally for antibiotic prophylaxis in biliary surgery. J Antimicrob Chemother 51 (2003) 459-462
3. Appelbaum P.C., and Hunter P.A. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents 16 (2000) 5-15
4. Paladino J.A. Is more than one quinolone needed in clinical practice?. Ann Pharmacother 35 (2001) 1085-1095
5. Aminimanizani A., Beringer P., and Jelliffe R. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials. Clin Pharmacokinet 40 (2001) 169-187
6. Lode H. Evidence of different profiles of side effects and drug-drug interactions among the quinolones - the pharmacokinetic standpoint. Chemotherapy 47 Suppl. 3 (2001) 24-31
7. Fish D.N., and Chow A.T. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet 32 (1997) 101-119
8. Lubasch A., Keller I., Borner K., Koeppe P., and Lode H. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers. Antimicrob Agents Chemother 44 (2000) 2600-2603
9. Kees F., Naber K.G., Schumacher H., and Grobecker H. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue. Chemotherapy 34 (1988) 437-443
10. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
11. Wagenlehner F.M.E., Kinzig-Schippers M., Tischmeyer U., et al. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose. Int J Antimicrob Agents 27 (2006) 7-14
12. 18F]trovafloxacin in healthy human subjects studied with positron emission tomography. Antimicrob Agents Chemother 42 (1998) 2048-2054
13. 18F]fleroxacin in healthy human subjects studied by using positron emission tomography. Antimicrob Agents Chemother 37 (1993) 2144-2152
14. Von Baum H., Böttcher S., Hoffmann H., and Sonntag H.-G. Tissue penetration of a single dose of levofloxacin intravenously for antibiotic prophylaxis in lung surgery. J Antimicrob Chemother 47 (2001) 719-730
15. Nomura H., Tsutsumi N., and Terasaka R. Levofloxacin prevented liver abscess and supportive cholecystitis following transcatheter arterial embolization for hepatocellular carcinoma. J Antimicrob Chemother 44 Suppl. A (1999) 104
16. Liu P., Müller M., and Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 19 (2002) 285-290
17. Bergogne-Bérézin E. Clinical role of protein binding of quinolones. Clin Pharmacokinet 41 (2002) 741-750
18. Smith R.P., Baltch A.L., Franke M.A., Michelsen P.B., and Bopp L.H. Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 45 (2000) 483-488
19. Kießlich R., Will D., Hahn M., et al. Ceftriaxone versus levofloxacin for antibiotic therapy in patients with acute cholangitis. Z Gastroenterol 41 (2003) 5-10 [in German]
20. Lee WJ, Che YS, Lee JH, Kim KS, Kim BY. Clinical efficacy and safety of intravenous levofloxacin in patients of abdominal operation. In: Program and Abstracts of the 10th International Congress on Infectious Diseases; Singapore, Malaysia; 2002 March 11-14.
21. Calza L, Manfredi R, Marinacci G, Fortunato L, Chiodo F. Liver abscess caused by Stenotrophomonas (Xanthomonas) maltophilia in a patient with acquired immunodeficiency syndrome. In: Program and Abstracts of the 10th International Congress on Infectious Diseases; Singapore, Malaysia; 2002 March 11-14.